The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Sony Biotechnology sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Sony Biotechnology Inc, United States Revenue

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Sony Biotechnology Inc (Sony Biotechnology), formerly iCyt Mission Technology Inc, is a medical products company that offers products and solutions for flow cytometry market. The company’s products portfolio include flow cytometers – cell analyzers, flow cytometers – cell sorters, and cell motion imaging systems among others. It also includes reagents such as anti-mouse antibodies, anti-rat antibodies, anti-human antibodies and others. Sony Biotechnology offers services such as maintenance, Software Revisions and unlimited telephone support for both instrument and software among others. The company markets its products through its distributors in the US, Japan, the UK and others. Sony Biotechnology is headquartered in San Jose, California, the US.

The key metrics of Sony Biotechnology related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:

As Sony Biotechnology is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Sony Biotechnology.

For a detailed understanding of the performance of Sony Biotechnology, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.